U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Guidance, Compliance, & Regulatory Information
  4. Surveillance: Post Drug-Approval Activities
  5. Prescription Drug Advertising and Promotional Labeling
  1. Surveillance: Post Drug-Approval Activities

Prescription Drug Advertising and Promotional Labeling

The mission of the Office of Prescription Drug Promotion (OPDP) is

"To protect the public health by assuring prescription drug information is truthful, balanced and accurately communicated. This is accomplished through a comprehensive surveillance, enforcement and education program, and by fostering better communication of labeling and promotional information to both healthcare professionals and consumers."

 

 



Back to Top